$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

초록

H. pylori가 공식적인 발암인자로 지정된 이후, 많은 연구가 H. pylori감염과 위암종 발생간의 연관관계를 지지해 왔다. 비록 몇몇 연구가 위암종 발생에 대한 H. pylori 감염의 부정적인 영향에 대한 증거를 제공하기는 했지만, 이들 연구가 H. pylori 감염률을 과소평가했다는 새로운 증거들이 제시되고 있다. 이 종설에서는 위암과 H. pylori의 역학적인 생태, H. pylori 감염과 위암종 발생의 연관관계를 지지하는 증거들, 제시된 위암종 발생의 기작, 그리고 H. pylori 감염의 위암종 발생에서의 잠재적인 병리학적 역할을 기존 연구들을 바탕으로 살펴보았다. 결론적으로 H. pylori 감염은 위암종 발생과 긍정적인 연관관계를 가진다는 것을 밝힐 수 있었다.

Abstract AI-Helper 아이콘AI-Helper

Ever since the World Health Organization classified Helicobacter pylori as a class I carcinogen, a variety of discussions over the actual role of H. pylori infection in gastric carcinogenesis has existed. Although a majority of researches support the positive correlation between H. pylori infection ...

주제어

참고문헌 (141)

  1. Ando, T., R. M. Peek Jr, Y. C. Lee, U. Krishna, K. Kusugami and M. J. Blaser. 2002. Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clin. Diagn. Lab. Immunol. 9, 167-175. 

  2. Archimandritis, A., J. Bitsikas, M. Tjivras, E. Anastasakou, N. Tsavaris, D. Kalogeras, P. Davaris and A. Fertakis. 1993. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. Ital. J. Gasiroenierol, 25, 368-371. 

  3. Asahi, M., T. Azuma, S. Ito, Y. Ito, H. Suto, Y. Nagai, M. Tsubokawa, Y. Tohyarna, S. Maeda, M. Ornata, T. Suzuki and C. Sasakawa, 2000. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 191. 593-602. 

  4. Asaka, M., T, Kimura, M. Kato, M. Kudo, K. Miki, K. Ogoshi, T. Kato, M. Tatsuta and D. Y. Graham DY. 1994. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73. 2691-2694. 

  5. Azuma, T., S. Ito, F. Sato, Y. Yamazaki, H. Miyaji, Y. Ito, H. Suto, M. Kuriyama, T. Kato and Y. Kohli Y. 1998. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 82, 1013-1018. 

  6. Banatvala, N., K. Mayo, F. Megraud, R. jennings, J. J. Deeks and R. A. Feldman. 1993. The cohort effect and Helicobacter pylori. J Infect. Dis. 168, 219-221. 

  7. Barreto-Zuniga, R. M. Maruyama, Y. Kato, K. Aizu, H. Ohta and T. Takekoshi. 1997. Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serologic and histological studies. J Gastroenterol. 32, 289-294. 

  8. Berkowicz, J. and A. Lee. 1987. Person-to-person transmission of Campylobacter pylori. Lance. 2, 680-681. 

  9. Blaser, M. J., K. Kobayashi, T. L. Cover, P. Cao, I. D. Feurer and G. I. Perez-Perez. 1993. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int. J. Cancer 55, 799-802. 

  10. Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann and A. Nomura. 1995. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55, 2111-2115. 

  11. Blot, W. J., S. S. Devesa, R. W. Kneller and J. F. Fraumeni Jr. 1991. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265, 1287-1289. 

  12. Brenner, H, G. Bode and H Boeing. 2000. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 118, 31-35. 

  13. Choi, N. W, D. W. Entwistle, W. Michaluk and N. Nelson. 1971. Gastric cancer in Icelanders in Manitoba. Isr. J. Med. Sci. 7, 1500-1508. 

  14. Chow, W. H., C. A. Swanson, J. Lissowska, F. D. Groves, L. H. Sobin, A. Nasierowska-Guttmejer, J. Radziszewski, J. Regula, A. W. Hsing, S. Jagannatha, W. Zatonski and W. J. Blot WJ. 1999. Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int. J. Cancer 81, 871-876. 

  15. Chyou, P. H, A. M. Nomura, J. H. Hankin and G. N. Stemmermann. 1990. A case-cohort study of diet and stomach cancer. Cancer Res 50, 7501-7504. 

  16. Correa, P., C. Cuello, E. Duque, L. C. Burbano, F. T. Garcia, O. Bolanos, C. Brown and W. Haenszei. 1976 Gastric cancer in Colombia. III. Natural history of precursor lesions. J. Natl. Cancer. Inst. 57, 1027-1035. 

  17. Correa, P., W. Haenszel, C. Cuello, D. Zavala, E. Fontham, G. Zarama, S. Tannenbaum, T. Collazos and B. Ruiz. 1990. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 50, 4737-4740. 

  18. Correa, P., G. Malcom, B. Schmidt, E. Fontham, B. Ruiz, J. C. Bravo, L. E. Bravo, G. Zarama and J. L. Realpe. 1998. Review article: antioxidant micronutrients and gastric cancer. Aliment Pharmacol. Ther, 12 (Suppl. 1), 73-82. 

  19. Correa, P. 1995. Helicobacter pylori and gastric carcinogenesis review. Am. J. Surg. Pathol. 19 (Suppl 1), S37-S43. 

  20. Correa, P. 1982. Precursors of gastric and esophageal cancer. Cancer 50, 2554-2565. 

  21. Crabtree, J. E., J. I. Wyatt, G. M. Sobala, G. Miller, D. S. Tompkins and J. N. M. Primrose. 1993. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 34, 1339-1343. 

  22. Cullen, D. J., B. J. Collins, K. J. Christiansen, J. Epis, J. R. Warren, I. Surveyor and K. J. Cullen. 1993. When is Helicobacter pylori infection acquired? Gut 34, 1681-1682. 

  23. Ekstrom, A. M., M. Held, L. E. Hansson, L. Engstrand and O. Nyren. 2001. Helicooacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121, 784-791. 

  24. El-Omar, E. M., K. Oien, L. S. Murray, A. EI-Nujumi, A. Wirz, D. Gillen, C. Williams, G. Fullarton and K. E. McColl. 2000. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role for H. pylori. Gastroenterology 118, 22-30. 

  25. Endo, S., T. Ohkusa, Y. Saito, K. Fujiki, I. Okayasu and C. Sato. 1995. Detection of Heliccoacier pylori infection in early stage gastlic cancer. A comparison between intestinal- and diffuse-type gastric adenocarcinomas. Cancer 75, 2203-2208. 

  26. Ernst, P. 1999. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol. Ther. 13 (Suppl. 1), 13-18. 

  27. Estevens, J., P. Fidalgo, T. Tendeiro, C. Chagas, A. Ferra, C. N. Leitao and F. C. Mira FC. 1993. Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. Eur. J. Cancer Prev. 2, 377-380. 

  28. Fan, X., H. Gunasena, Z. Cheng, R. Espejo, S. E. Crowe, P. B. Ernst and V. E. Reyes. 2000. Helicooaaer pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J. Immunol. 165, 1918-1924. 

  29. Fiedorek, S. C., H M. MaIaty, D. L. Evans, C. L. Pumphrey, H. B. Casteel, D. J. Evans and D. Y. Graham DY. 1991. Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics 88, 578-582. 

  30. Figura, N. 1996. Mouth-to-mouth resuscitation and Helicobacter pylori infection. Lancet 347, 1342-1342. 

  31. Forman, D., D. G. Newell, F. Fullerton, J. W. Yarnell, A. R. Stacey and N. Wald. 1991. Association between infection with Heliccoacier pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302, 1302-1305. 

  32. Forman, D., P. Webb and J. Parsonnet. 1994. H. pylori and gastlic cancer. Lancet 343, 243-244. 

  33. Forman, D. and P. M. Webb. 1994. Helicobacter pylori: Basic Mechanisms to Clinical Cure. Kluwer Academic, Dordecht, The Netherlands. 

  34. Forman, D. 1995. The prevalence of Helicobacter pylori infection in gastric cancer review. Aliment Pharmacol. Ther. 9 (Suppl. 2), 71-76 

  35. Foryst-Ludwig, A. and M. Naumann. 2000. p21-activated kinase 1 activates the nuclear factor kappa B (NF- $\kappa$ B)-inducing kinase-I $\kappa$ B kinases NF- $\kappa$ B pathway and proinflammatory cytokines in Helicobacter pylori infection. J. Biol. Chem. 275, 39779-39785. 

  36. Fox, J. G., P. Correa, N. S. Taylor, A. Lee, G. Otto, J. C. Murphy and R. Rose. 1990. Helicobacter mustelae-associa ted gastritis in ferrets. An animal model of Helicobacier pylori gastritis in humans. Gastroenterology 99, 352-361. 

  37. Fox, J. G., C. A. Dangler, W. Sager, R. Borkowski and J. M. Gliatto. 1997. Helicobacter mustelae-associated gastric adenocarcinoma in ferrets (Mustela putorius furo). Vet. Pathol. 34, 225-229. 

  38. Fuchs, C. S. and R. J. Mayer. 1995. Gastric carcinoma review. N. Engl. J. Med. 333, 32-41. 

  39. Fukao, A., S. Komatsu, Y. Tsubono, S. Hisamichi, H, Ohori, T. Kizawa, N. Ohsato, N. Fujino, N. Endo and M. Iha M. 1993. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross sectional study. Cancer Causes Control. 4, 307-312. 

  40. Fukuda, H., D. Saito, S. Hayashi, H, Hisai, H, Ono, S. Yoshida, Y. Oguro, T. Noda, T. Sato and M. Katoh. 1995. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn. J. Cancer Res. 86, 64-71. 

  41. Garcia-Closas, R., C. A. Gonzalez, A. Agudo and E. Riboli. 1999. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10, 71-75. 

  42. Ge, Z., Y. Feng, C. A. Dangler, S. Xu, N. S. Taylor and J. G. Fox. 2000. Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach. Microb. Pathol. 29, 279-287. 

  43. Gong, C., R. Mera, J. C. Bravo, B. Ruiz, R. Diaz-EscamilIa, E. T. Fontham, P. Correa and J. D. Hunt. 1999. KRAS mutations predict progression of preneoplastic gastric lesions. Cancer Epidemiol. Biomarkers Prev. 8, 167-171. 

  44. Coto, Y., T. Ando, K. Yamamoto, A. Tamakoshi, E. El-Omar and H, Coto. 2006. Hamajima N. Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among H. pylori seropositive Japanese. Int. J. Cancer 189, 820-827. 

  45. Haenszel, W., M. Kurihara, M. Segi and R. K. Lee. 1972. Stomach cancer among Japanese in Hawaii. J. Natl. Cancer Inst. 49, 969-988. 

  46. HaenszeI, W. and M. Kurihara. 1968. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst. 40, 43-68. 

  47. Haenszel, W. 1961. Cancer mortality among the foreign born in the United States. J. Natl. Cancer Inst. 26, 37-132. 

  48. Hansson, L. E., L. Engstrand, O. Nyren, D. J. Evans Jr, A. Lindgren, R. Bergstrom, B. Andersson, L. Athlin, O. Bendtsen and P. Tracz. 1993. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 105, 1098-1103. 

  49. Held, M., L. Engstrand, L. E. Hansson, R. Bergstrom, T. Wadstrom and O. Nyren. 2004. Is the association between H. pylori and gastric cancer confined to CagA-positive strains? Helicobacter 9, 271-277. 

  50. Hill, M. J. 1995. Diet and cancer: a critical review of scientific evidence. Eur. J. Cancer Prev. 4 (Suppl. 2), 3-24. 

  51. Hirata, Y., S. Maeda, Y. Mitsuno, M. Akanuma, Y. Yamaji, K. Ogura, H, Yoshida, Y. Shiratori and M. Omata. 2001. Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect. Immun. 69, 3965-3971. 

  52. Hirayama, F., S. Takagi, E. Iwao, Y. Yokoyama, K. Haga and S. Hanada. 1999. Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J. Gastroenterol. 34, 450-454. 

  53. Holcombe, C, S. Tsimiri, J. Eldridge and D. M. Jones. 1993. Prevalence of antibody to Helicobacter pylori in children in northern Nigeria. Trans. R. Soc. Trop. Med. Hyg. 87, 19-21. 

  54. Honda, S., T. Fujioka, M. J. Tokieda, R. Satoh, A. Nishizono and M. Nasu. 1998. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 58, 4255-4259. 

  55. Houghton, J. M., L. M. Bloch, M. Goldstein, S. Von Hagen and R. M. Korah. 2000. ln vivo disruption of the fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. J. Infect. Dis. 182, 856-864. 

  56. Howson, C. P., T. Hiyama and E. L. Wynder. 1986. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 8, 1-2. 

  57. Hu, P. J., Y. Y. Li, H.L. Lin, S. M. Zhou, G. Du, M. H. Chen, H. M. Mitchell and S. L. Hazell. 1995. Gastric atrophy and regional variation in upper gastrointestinal disease. Am. J. Gastroenterol. 90, 1102-1106. 

  58. Hu, P. J., Y. Y. Li, M. H Zhou, M. H Chen, G. G. Du, B. J. Huang, H. M. Mitchell and S. L. Hazell. 1995. Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut 36, 198-202. 

  59. Hunt, J. D., R. Mera, A. Strimas, A. T. Gillespie, B. Ruiz, P. Correa and E. T. Fontham. 2001. KRAS mutations are not predictive for progression of preneoplastic gastric lesions. Cancer Epidemiol. Biomarkers Prev. 10, 79-80. 

  60. Hunt, R. H. 1996. The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes. Scand. J. Gastroenterol. Suppl 220, 3-9. 

  61. Icatlo, F. C., H. Goshima, N. Kimura and Y. Kodama. 2000. Acid-dependent adherence of Helicobacter pylori urease to diverse polysaccharides. Gastroenterology 119, 358-367. 

  62. Imrie, C., M. Rowland, B. Bourke and B. Brumm. 2001. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 107, 373-380. 

  63. Innocenti, M., A. M. Svennerholm and M. Quiding-Jarbrink, 2001. Helicobacter pylori lipopolysaccharides preferentially induce CXC chemokine production in human monocytes. Infect. Immun. 69, 3800-3808. 

  64. Isomoto, H, Y. Mizuta, M. Miyazaki, F. Takeshima, K. Omagari, K. Murase, T. Nishiyama, K. Inoue, I. Murata and S. Kohno. 2000. Implication of NF-kappaB in Helicobacter pylori-associated gastritis. Am. J. Gastroenterol. 95, 2768-2776 

  65. Joossens, J. V., M. J. Hill and P. Elliott. 1996. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Resesarch Group. Int. J. Epidemiol. 25, 494-504. 

  66. Kaaks, R., A. J. Tuyns, M. Haelterman and E. Riboli. 1998. Nutrient intake patterns and gastric cancer risk: a casecontrol study in Belgium. Int. J. Cancer 78, 415-420. 

  67. Karnes, W. E. Jr, I.M. Samloff, M. Siurala, M. Kekki, P. Sipponen and S. W. Kim. 1991. Positive serum antibody and negative tissue staining for in subjects with atrophic body gastritis. Gastroenterology 101, 167-174. 

  68. Kawahara, T., S. Teshima, A. Oka, T. Sugiyama, K. Kishi and K. Rokutan. 2001. Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69, 4382-4389. 

  69. Keates, S., Y. S. Hitti, M. Upton and C. P. Kelly. 1997. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cels. Gastroenterology 113, 1099-1109. 

  70. Keates, S., A. C. Keates, M. Warny, R M. Peek Jr. P. G. Murray and C. P. Kelly. 1999. Differential activation of mitogenactivated protein kinases in ACS gastric epithelial cells by cagpositive and cag-Helicobacter pylori. J. Immunol. 163, 5552-5559. 

  71. Korean Ministry of Health and Welfare-National Cancer Center. Statistics of Castric Cancer-related Death, 1983-2005. 

  72. Kuipers, E. J., A. M. Uyterlinde, A. S. Pena, R Roosendaal, G. Pals, G. F. Nelis, H. P. Festen and S. G. Meuwissen. 1995. Long-term sequelae of Helicobacter pylori gastritis. Lancet 345, 1525-1528. 

  73. Kuwahara, H., Y. Miyamoto, T. Akaike, T. Kubota, T. Sawa, S. Okamoto and H. Maeda. 2000. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production. Infect. Immun. 68, 4378-4383. 

  74. La, Vecchia, C., S. E. Munoz, C. Braga, E. Fernandez and A. Decarli. 1997. Diet diversity and gastric cancer. Int. J. Cancer 72, 255-257. 

  75. Labenz, J., A. L. Blum, E. Bayerdorffer, A. Meining, M. Stolte and G. Borsch. 1997. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux oesophagitis. Gastroenterology 112, 1442-1447. 

  76. Lauren, P. 1965. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 64, 31-49. 

  77. Lindkvist, P., D. Asrat, T. Nilsson, E. Tsega, G. L. Olsson and B. Wretlind. 1996. Age at acquisition of Helicobacter pylori infection: comparison of a high and low prevalence country. Scand. J. Infect. Dis. 28, 181-184. 

  78. Maeda, S., H. Yoshida, K. Ogura, Y. Mitsuno, Y. Hirata, Y. Yamaji, M. Akanuma, Y. Shiratori and M. Omata. 2000. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 119, 97-108. 

  79. Mannick, E. E., L. E. Bravo, G. Zarama, J. L. Realpe, X. J. Zhang, B. Ruiz, E. T. Fontham, R. Mera, M. J. Miller and P. Correa. 1996. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56, 3238-3243. 

  80. Martin-de-Argila, C, D. Boixeda, C. Redondo, I. Alvarez, J. P. Gisbert and R. Canton. 1997. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. Scand. J. Gastroenterol. 32, 303-307. 

  81. Martino, M. C, R. A. Stabler, Z. W. Zhang, M. J. Farthing, B. W. Wren and N. Dorrell. 2001. Helicobacter pylori pore-forming cytolysin orthologue TlyA possesses in vitro hemolytic activity and has a role in colonization of the gastric mucosa. Infect. Immun. 69, 1697-1703. 

  82. McCallion, W. A., L. J. Murray, A. G. Bailie, A. M. Dalzell, D. P. O'Reilly and K. B. Bamford. Helicobacter pylori infection in children: relation with current household living conditions. Gut 39, 18-21. 

  83. McColl, K. E., E. El-Omar and D. Gillen. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br. Med. Bull. 54, 121-138. 

  84. Miehlke, S., A. Hackelsberger, A. Meining, U. von Arnim, P. Muller, T. Ochsenkuhn, N. Lehn, P. Malfertheiner, M. Stolte and E. Bayerdorffer. 1997. Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int. J. Cancer 73, 837-839. 

  85. Mori, N., A. Ueda, R. Geleziunas, A. Wada, T. Hirayama, T. Yoshimura and N. Yamamoto. 2001. Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB. Infect. Immun. 69, 1280-1286. 

  86. Morita, M., H. Kuwano, H. Baba, A. Taketomi, S. Kohnoe, H. Tomoda, K. Araki, H. Saeki, K. Kitamura and K. Sugimachi. 1998. Multifocal occurrence of gastric carcinoma in patients with a family history of gastric carcinoma. Cancer 83, 1307-1311. 

  87. Moss, S. F., J. Calam, B. Agarwal, S. Wang and P. R. Holt. 1996. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 38, 498-501. 

  88. Moss, S. F., E. M. Sordillo, A. M. Abdalla, V. Makarov, Z. Hanzely, G. I. Perez-Perez, M. J. Blaser and P. R. Holt. 2001. Increased gastric epithelial cell apoptosis associated with colonization with CagA positive Helicobacter pylori strains. Cancer Res. 61, 1406-1411. 

  89. Munoz, N. and J. Asvall. 1971. Time trends of intestinal and diffuse types of gastric cancer in Norway. Int. J. Cancer 8, 144-157. 

  90. Nardone, G., S. Staibano, A. Rocco, E. Mezza, F. P. D'armiento, L. Insabato, A. Coppola, G. Salvatore, A. Lucariello, N. Figura, G. De Rosa and G. Budillon. 1999. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 444, 789-799. 

  91. Naumann, M., S. Wessler, C. Bartsch, B. Wieland, A. Covacci, R. Haas and T. F. Meyer. 1999. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem. 274, 31655-31662. 

  92. Neel, B. G., H. Gu and L. Pao. 2003. The 'Shp'ing news: SH2 domaincontaining tyrosine phosphatases in cell signaling. Trends Biothem. Sci. 28, 284-293. 

  93. Neugut, A. I., M. Hayek and G. Howe. 1996. Epidemiology of gastric cancer review. Semin. Oncol. 23, 281-291. 

  94. Nomura, A., G. N. Stemmermann, P. H. Chyou, I. Kato, G. I. Perez-Perez and M. J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325, 1132-1136. 

  95. Odenbreit, S., B. Gebert, J. Puls, W. Fischer and R. Haas. 2001. Interaction of Helicobacter pylori with professional phagocytes: rule of the cag pathogenicity island and translocation, phosphorylation and processing of CagA. Cell. Microbiol. 3, 21-31. 

  96. Odenbreit, S., J. PuIs, B. Sedlmaier, E. Gerland, W. Fischer and R. Haas. 2000. Translocation of H. pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497-1500. 

  97. Palli, D., A. Decarli, F. Cipriani, F. Sitas, D. Forman, D. Amadori, C. Avellini, A. Giacosa, P. Manca and A. Russo. 1993. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol. Biomarkers Prev. 2, 37-40. 

  98. Park, I. S., Y. C. Lee, H. J. Park, T. I. Kim, S. I. Lee, H. Kim, K. S. Chung and Y. J. Lee-Kim. 2001. Helicobacter pylori infection in Korea. Yonsei Med. J. 42, 457-470. 

  99. Parkin, D. M., C. S. Muir, S. L. Whelan, Y. T. Gao, J. Ferlay and J. Powell. 1992. Cancer Incidence in Five Continents, VI. Lyon, France: International Agency for Research on Cancer 

  100. Parkin, D. M., P. Pisani and J. Ferlay. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 54, 594-606. 

  101. Parkin, D. M., S. L. Whelan, J. Ferlay, L. Raymond and J. Young. 1997. Cancer Incidence in Five Continents, VII. Lyon, France: International Agency for Research on Cancer 

  102. Parsonnet, J., G. D. Friedman, N. Orentreich and H. Vogelman. 1997. Risk for gastric cancer in people with CagA positive or CagA negative H. pylori infection. Gut 40, 297-301. 

  103. Ohata, H., S. Kitauchi, N. Yoshimura, K. Mugitani, M. Iwane, H. Nakamura, A. Yoshikawa, K. Yanaoka, K. Arii, H. Tamai, Y. Shimizu, T. Takeshita, O. Mohara and M. Ichinose. 2004. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int. J. Cancer 109, 138-143. 

  104. Parsonnet, J. G, D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127-1131. 

  105. Parsonnet, J., S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke, E. Jellum, N. Orentreich, J. H. Vogelman and G. D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330, 1267-1271. 

  106. Peek, R. M. Jr. 2001. IV: Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G525-G530. 

  107. Perez-Perez, G. I., B. M. Dworkin, J. E. Chodos and M. J. Blaser. 1988. Campylobacter pylori antibodies in humans. Ann. Intern. Med. 109, 11-17 

  108. Pisani, P., D. M. Parkin, N. Munoz and J. Ferlay, 1997. Cancer and infection. Estimates of the attributable fraction in 1990. Cancer Epidemiol. Biomarkers Prev. 6, 387-400. 

  109. Rudi, J., C. Kolb, M. Maiwald, I. Zuna, A. von Herbay, P. R. Galle and W. Stremmei. 1997. Serum antibodies against with Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig. Dis. Sci. 42, 1652-1659. 

  110. Rudi, J., M. Muller, A. von Herbay, I. Zuna, R. Raedsch, W. Stremmel and U. Rath U. 1995. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand. J. Gastroenterol. 30, 958-963. 

  111. Salama, N. R., G. Otto, L. Tompkins and S. Falkow. 2001. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect. Immun. 69, 730-736. 

  112. Segal. E. D., J. Cha, J. Lo, S. Falkow and L. S. Tompkins. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by H. pylori. Proc. Natl. Acad. Sci. USA 96, 4559-14564. 

  113. Segal. E. D., C. Lange, A. Covacci, L. S. Tompkins and S. Falkow. 1997. Induction of host signal transduction pathways by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 94, 7595-7599 

  114. Severson, R. K. and S. Davis. 1990. Increasing incidence of primary gastric lymphoma. Cancer 66, 1283-1287. 

  115. Shibata, T., I. Imoto, Y. Ohuchi, Y. Taguchi, S. Takaji, N. Ikemura, K. Nakao and T. Shima. 1996. Helicobacter pylori infection in patients with gastric carcinoma in biopsy and surgical resection specimens. Cancer 77, 1044-1049. 

  116. Shimoyama, T., S. Fukuda, M. Tanaka, T. Mikami, A. Munakata and J.E. Crabtree. 1998. CagA seropositivity associated with development of gastric cancer in a Japanese population. J. Clin. Pathol. 51, 225-228. 

  117. Shirin, H, E. M. Sordillo, T. K. Kolevska, H. Hibshoosh, Y. Kawabata, S. H. Oh, J. F. Kuebler, T. Delohery, C. M. Weghorst, I. B. Weinstein and S. F. Moss. 2000. Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1). Infect. Immun. 68, 5321-5328. 

  118. Sierra, R., N. Munoz, A.S. Pena, I. Biemond, W. van Duijn, C. B. Lamers, S. Teuchmann, S. Hernandez and P. Correa. 1992. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol. Biomarkers Prev. 1, 449-454. 

  119. Sipponen, P., H Hyvarinen, K. Seppala and M. J. Blaser. 1998. Review articles: pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther. 12(Suppl, 1), 61-71. 

  120. Sipponen, P., T. U. Kosunen, J. Valle, M. Riihela and K. Seppala. 1992. Helicobacter pylori infection and chronic gastritis in gastric cancer. J. Clin. Pathol. 45, 319-323. 

  121. Sipponen, P. 1992. Helicobacter pylori infection-a common worldwide environmental risk factor for gastric cancer? Endoscopy 24, 424-427. 

  122. Sipponen, P. 1995. Helicobacter pylori: a cohort phenomenon review. Am. J. Surg. Pathol. 19 (Suppl 1), S30-S36. 

  123. Skinner, M. and E. G. Zimbabwe: Bulawayo cancer registry 1973-1977. In: D.M. Parkin, ed. 1986. Cancer Occurrence in Developing Countries. Lyon, France: International Agency for Research on Cancer; pp. 126-128. 

  124. Stein, M., R. Rappuoli and A. Covacci. 2000. Tyrosine phosphorylation of the H. pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. USA 97, 1263-1268. 

  125. Sugiyama, A, F. Maruta, T. Ikeno, K. Ishida, S. Kawasaki, T. Katsuyama, N. Shimizu and M. Tatematsu. 1998. Helicobacterpylori infection enhances N-metyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res. 58, 2067-2069. 

  126. Sullivan, P. B., J .E. Thomas, D. G. Wight, G. Neale, E. J. Eastham, T. Corrah, N. Lloyd-Evans and B. M. Greenwood. 1990. Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch. Dis. Child. 65, 189-191. 

  127. Svendsen, J. H., C. Dahl, L. B. Svendsen and P. M. Christiansen. 1986. Gastric cancer risk in achlorhydric patients. A long-term follow-up study. Scand. J. Gastroenterol. 21, 16-20. 

  128. Talley, N. J., A. R. Zinsmeister, A Weaver, E. P. DiMagno, H. A Carpenter and M. J. Blaser. 1991. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst. 83, 1734-1739. 

  129. Tang, T. L., R. M. Freeman Jr, A. M. O'Reilly, B. G. Neel and S. Y. Sokol. 1995. The SH2-containing protein-tyrosine phosphatase SHPTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80, 473-483. 

  130. Taylor, D. N. and M. J. Blaser. 1991. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev. 13, 42-59. 

  131. Thiede, C., A. Morgner, B. Alpen, T. Wundisch, J. Herrmann, M. Ritter, G. Ehninger, M. Stolte, E. Bayerdorffer and A. Neubauer. 1997. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? Gastroenterology 113, S61-S64. 

  132. Valle, J., M. Kekki, P. Sipponen, T. Ihamaki and M. Siurala. 1996. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand. J. Gastroenterol. 31, 546-550. 

  133. Villako, K., M. Kekki, H. I. Maaroos, P. Sipponen, R. Uibo, R. Tammur and A. Tamm. 1991. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand. J. Gastroenterol. Suppl, 186, 135-141. 

  134. Wang, T. C, J. R. Goldenring, C. Dangler, S. Ito, A. Mueller, W. K. Jeon, T. J. Koh and J. G. Fox. 1998. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 114, 675-689. 

  135. Ward, M. H. and L. Lopez-Carriollo, 1999. Dietary factors and the risk of gastric cancer in Mexico City. Am. J. Epidemiol. 149, 925-932. 

  136. Watanabe, T., M. Tada, H. Nagai and M. Nakao. 1998. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115, 642-648. 

  137. Webb, P. M., M. C. Yu, D. Forman, B. E. Henderson, D. G. Newell, J. M. Yuan, Y. T. Gao and R. K. Ross. 1996. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int. J. Cancer 67, 603-607. 

  138. Wotherspoon, A. C. C. Ortiz-Hidalgo, M. R. Falzon and P. G. Isaacson. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338, 1175-1176. 

  139. Wu, M. S., S. Y. Chen, C. T. Shun, W. J. Lee, H. P. Wang, T. H. Wang, C. J. Chen and J. T. Lin. 1997. Increased prevalence of Helicobacter pylori infection among patients affected with intestinal-type gastric cancer at non-cardiac locations. J. Gastroenterol. Hepatol. 12, 425-428. 

  140. Yamaoka, Y., H. M. El-Zimaitv, O. Gutierrez, N. Figura, J. G.Kim, T. Kodama, K. Kashima and D. Y. Graham. 1999. Relationship between the CagA 3' repeat region of H. pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117, 342-349. 

  141. Zhang, Z. W., S. E. Patchett, D. Perrett, P. H. Katelaris, P, Domizio and M. J. Farthing. 1998. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 43, 322-326. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로